An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a study led by investigators at Weill Cornell Medicine. The finding suggests...
Read more
New Treatment Option for Advanced Urothelial Cancer Patients Shows Promise in a Phase 2 Clinical Trial A new treatment for advanced urothelial cancer was effective with tolerable side effects in an international, multi-center phase 2...
Read more
Germline Whole-Exome Sequencing Reveals Potential New Treatment Opportunities in Bladder Cancers DECEMBER 8, 2020 A significant percentage of patients with urothelial cancers have inherited gene variants that drive the progression of these...
Read more
Dr. Bishoy Faltas Works to Develop More Effective Therapies for Bladder Cancer Each year, 80,000 people in the United States are newly diagnosed with bladder cancer, and more than 17,000 lose their lives due to the disease. It ranks as the fourth ...
Read more
World-Renowned Medical Oncologist Cora Sternberg, M.D. Joins the Englander Institute for Precision Medicine as Clinical Director The Englander Institute for Precision Medicine (EIPM) is excited to announce that world-renowned medical oncologist...
Read more
WE ARE PLEASED TO INTRODUCE YOU TO ANOTHER GIFTED EIPM INVESTIGATOR, BISHOY FALTAS, M.D., WHO STUDIES BLADDER CANCER. AMONG OTHER RESEARCH GOALS, HIS TEAM WILL ESTABLISH BLADDER CANCER ORGANOIDS, WHICH ARE MINI TUMOR ‘AVATARS’ FROM EACH PATIENT...
Read more